[Intrinsic sympathicomimetic activity of beta blockers].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000402:Airway Obstruction / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D006017:Glycolipids / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D013566:Sympathomimetics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D006017:Glycolipids; D013566:Sympathomimetics
Activité sympathico-mimétique intrinsèque (ASI) des bêtabloquants.